Structures by: Taylor L. S.
Total: 8
Bifonazole
C22H18N2
Acta Crystallographica Section E (2010) 66, 10 o2649
a=7.9737(7)Å b=6.2591(6)Å c=33.265(3)Å
α=90.00° β=93.805(8)° γ=90.00°
Felbinac
C14H12O2
Acta Crystallographica Section E (2010) 66, 10 o2609
a=46.248(19)Å b=6.465(3)Å c=7.470(3)Å
α=90.00° β=90.00° γ=90.00°
Dibucaine
C20H29N3O2
Acta Crystallographica Section E (2010) 66, 12 o3189
a=4.93230(10)Å b=7.20440(10)Å c=26.9914(19)Å
α=94.080(7)° β=90.611(6)° γ=94.728(7)°
5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione
C12H10F3N3O4
Acta Crystallographica Section E (2012) 68, 3 o591
a=12.3304(9)Å b=9.8875(2)Å c=12.2118(3)Å
α=90.00° β=117.322(8)° γ=90.00°
2-ethoxybenzamide
C9H11NO2
Crystal Growth & Design (2012) 12, 12 6110
a=5.0512(8)Å b=12.027(3)Å c=14.251(3)Å
α=90.00° β=96.774(17)° γ=90.00°
2-ethoxybenzamide
C9H11NO2
Crystal Growth & Design (2012) 12, 12 6110
a=5.0339(5)Å b=11.8782(13)Å c=14.1229(15)Å
α=90.00° β=96.590(10)° γ=90.00°
Ethenzamide - 2,6-dihydroxybenzoic acid
C16H17NO6
Crystal Growth & Design (2012) 12, 12 6110
a=7.3241(7)Å b=13.5843(9)Å c=14.8048(10)Å
α=90.00° β=95.715(7)° γ=90.00°
2-ethoxybenzamide 3,5-dichlorobenzoic acid
C9H11NO2,C7H4Cl2O2
Crystal Growth & Design (2012) 12, 12 6110
a=14.9456(9)Å b=14.5611(6)Å c=7.7198(5)Å
α=90.00° β=103.794(6)° γ=90.00°